Simmaron Rising: An ME/CFS Blog Featured Blog Posts Nov 26, 2024 Simmaron Partners with AgelessRx to Advance Groundbreaking Low-Dose Rapamycin Trial for ME/CFS, Long-COVID, and IACCs Nov 26, 2024 Nov 26, 2024 Nov 21, 2024 BBC article features Simmaron! Nov 21, 2024 Nov 21, 2024 Nov 2, 2024 Our new publication details findings on high BH4 in an ME subset! Nov 2, 2024 Nov 2, 2024 Sep 10, 2024 Watch Simmaron’s presentation at the 2024 Invest in ME Research International ME Conference (IIMEC16) Sep 10, 2024 Sep 10, 2024 Treatment 3/26/17 Treatment 3/26/17 Through the "Valley of Death": Dr. Pridgen, Fibromyalgia and the Looming Trials Read More Pathogens, Treatment 10/17/16 Pathogens, Treatment 10/17/16 The Pridgen Revolution? Dr. Pridgen on Bringing His Antiviral Approach to Fibromyalgia To Market Read More Pathogens, Treatment 4/27/15 Pathogens, Treatment 4/27/15 Dr. Pridgen on Doses, Fixing Broken Bodies and Why the Next Fibromyalgia Trials Will Be Better Read More Pathogens, Treatment 11/18/14 Pathogens, Treatment 11/18/14 Drug Combo in Pridgen Antiviral Fibromyalgia Trial Identified - Some Results Available Read More Treatment 6/8/14 Treatment 6/8/14 Brief Report From Dr. Prigden on the Fibromyalgia Antiviral Trial - and the Future Chronic Fatigue Syndrome One Read More
Treatment 3/26/17 Treatment 3/26/17 Through the "Valley of Death": Dr. Pridgen, Fibromyalgia and the Looming Trials Read More
Pathogens, Treatment 10/17/16 Pathogens, Treatment 10/17/16 The Pridgen Revolution? Dr. Pridgen on Bringing His Antiviral Approach to Fibromyalgia To Market Read More
Pathogens, Treatment 4/27/15 Pathogens, Treatment 4/27/15 Dr. Pridgen on Doses, Fixing Broken Bodies and Why the Next Fibromyalgia Trials Will Be Better Read More
Pathogens, Treatment 11/18/14 Pathogens, Treatment 11/18/14 Drug Combo in Pridgen Antiviral Fibromyalgia Trial Identified - Some Results Available Read More
Treatment 6/8/14 Treatment 6/8/14 Brief Report From Dr. Prigden on the Fibromyalgia Antiviral Trial - and the Future Chronic Fatigue Syndrome One Read More
